Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.65) by 36.92 percent. This is a 47.44 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $23.555 million which missed the analyst consensus estimate of $25.200 million by 6.53 percent. This is a 567.66 percent increase over sales of $3.528 million the same period last year.